product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
KRAS Antibody (3B10-2F2) - Azide and BSA Free
catalog :
H00003845-M01
quantity :
0.1 mg
price :
519 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
3B10-2F2
reactivity :
human, mouse
application :
western blot, ELISA, immunocytochemistry, immunoprecipitation
more info or order :
citations: 18
Reference
Chapeau E, Sansregret L, Galli G, Ch xe8 ne P, Wartmann M, Mourikis T, et al. Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers. Nat Cancer. 2024;5:1102-1120 pubmed publisher
Amen A, Loughran R, Huang C, Lew R, Ravi A, Guan Y, et al. Endogenous spacing enables co-processing of microRNAs and efficient combinatorial RNAi. Cell Rep Methods. 2022;2:100239 pubmed publisher
Bill A, Espinola S, Guthy D, Haling J, Lanter M, Lu M, et al. EndoBind detects endogenous protein-protein interactions in real time. Commun Biol. 2021;4:1085 pubmed publisher
Lee S, Jeon Y, Kang J, Jang H, Lee H, Kim S. The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer. Cancers (Basel). 2020;12: pubmed publisher
Yaqoob A, Li W, Liu V, Wang C, Mackedenski S, Tackaberry L, et al. Grifolin, neogrifolin and confluentin from the terricolous polypore Albatrellus flettii suppress KRAS expression in human colon cancer cells. PLoS ONE. 2020;15:e0231948 pubmed publisher
Sherekar M, Han S, Ghirlando R, Messing S, Drew M, Rabara D, et al. Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer. J Biol Chem. 2020;295:1105-1119 pubmed publisher
Cao S, Chung S, Kim S, Li Z, Manor D, Buck M. K-Ras G-domain binding with signaling lipid phosphatidylinositol (4,5)-phosphate (PIP2): membrane association, protein orientation, and function. J Biol Chem. 2019;294:7068-7084 pubmed publisher
Ahmed T, Adamopoulos C, Karoulia Z, Wu X, Sachidanandam R, Aaronson S, et al. SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent Tumors. Cell Rep. 2019;26:65-78.e5 pubmed publisher
García Berrocoso T, Llombart V, Colàs Campàs L, Hainard A, Licker V, Penalba A, et al. Single Cell Immuno-Laser Microdissection Coupled to Label-Free Proteomics to Reveal the Proteotypes of Human Brain Cells After Ischemia. Mol Cell Proteomics. 2018;17:175-189 pubmed publisher
Kuracha M, Thomas P, Loggie B, Govindarajan V. Bilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignancies. PLoS ONE. 2017;12:e0179510 pubmed publisher
Forzati F, De Martino M, Esposito F, Sepe R, Pellecchia S, Malapelle U, et al. miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene. BMC Cancer. 2017;17:170 pubmed publisher
Madureira P, Bharadwaj A, Bydoun M, Garant K, O Connell P, Lee P, et al. Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10. Oncotarget. 2016;7:47720-47737 pubmed publisher
Ambrosini G, Khanin R, Carvajal R, Schwartz G. Overexpression of DDX43 mediates MEK inhibitor resistance through RAS Upregulation in uveal melanoma cells. Mol Cancer Ther. 2014;13:2073-80 pubmed publisher
King S, Bray S, Galbraith S, Christie L, Fleming S. Evidence for aldosterone-dependent growth of renal cell carcinoma. Int J Exp Pathol. 2014;95:244-50 pubmed publisher
Subramani A, Alsidawi S, Jagannathan S, Sumita K, Sasaki A, Aronow B, et al. The brain microenvironment negatively regulates miRNA-768-3p to promote K-ras expression and lung cancer metastasis. Sci Rep. 2013;3:2392 pubmed publisher
Valtorta E, Misale S, Sartore Bianchi A, Nagtegaal I, Paraf F, Lauricella C, et al. KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy. Int J Cancer. 2013;133:1259-65 pubmed publisher
Hsu S, Lee W. Progesterone receptor activation of extranuclear signaling pathways in regulating p53 expression in vascular endothelial cells. Mol Endocrinol. 2011;25:421-32 pubmed publisher
Fuentes Calvo I, Blázquez Medela A, Santos E, Lopez Novoa J, Martinez Salgado C. Analysis of k-ras nuclear expression in fibroblasts and mesangial cells. PLoS ONE. 2010;5:e8703 pubmed publisher
product information
master code :
H00003845-M01
SKU :
H00003845-M01
product name :
KRAS Antibody (3B10-2F2) - Azide and BSA Free
unit size :
0.1 mg
description :
The KRAS Antibody (3B10-2F2) - Azide and BSA Free from Novus is a mouse monoclonal antibody to KRAS. This antibody reacts with human,mouse. The KRAS Antibody (3B10-2F2) - Azide and BSA Free has been validated for the following applications: Immunoprecipitation,Western Blot,Immunocytochemistry/ Immunofluorescence,ELISA.
target :
KRAS
category :
Primary Antibodies
buffer :
In 1x PBS, pH 7.4
clonality :
Monoclonal
clone :
3B10-2F2
conjugate :
Unconjugated
host :
Mouse
immunogen :
MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDS
YRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGF
LCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNK
CDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAF
YTLVREIRKHKEKMSKDGKKKKKKSKTKCVIM
KRAS (AAH13572, 1 a.a. ~ 188 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
isotype :
IgG1 Kappa
purity :
IgG purified
species :
Human,Mouse
specificity :
KRAS - v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
gene symbol :
KRAS
accessionNumbers :
AAH13572
applications :
Immunoprecipitation,Western Blot,Immunocytochemistry/ Immunofluorescence,ELISA
USD :
519 USD
alt names :
cellular c-Ki-ras2 proto-oncogene, c-Ki-ras, C-K-RAS, GTPase KRas, Ki-Ras, Kirsten rat sarcoma-2 viral (v-Ki-ras2) oncogene homolog, K-Ras 2, K-ras p21 protein, KRAS1, K-RAS2A, K-RAS2B, KRAS2NS3, K-RAS4A, K-RAS4B, NS, oncogene KRAS2, PR310 c-K-ras oncogene, RASK2c-Kirsten-ras protein, transforming protein p21, v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog, v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
storage :
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
more info or order :
company information
Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com
3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.